Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 2 × Inflammatory Bowel Diseases × MEDI2070 × Clear all

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 2

Sponsor

Conditions

Inflammatory Bowel Diseases 2 Crohn Disease 2

Interventions

MEDI2070 2 Tea 1 Surgical Tape 1 Medical Marijuana 1 Lidocaine 1 Laparoscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01714726 2021-05-26

Evaluation of Efficacy and Safety of MEDI2070 in Patients With Active, Moderate-to-severe Crohn's Disease.

AstraZeneca

Phase 2 Completed

121 enrolled 22 charts

Crohn Disease, Inflammatory Bowel Diseases

NCT02574637 2021-05-26

Evaluation of Efficacy and Safety of Brazikumab (MEDI2070) in Participants With Active, Moderate to Severe Crohn's Disease

AstraZeneca

Phase 2 Terminated

29 enrolled 25 charts

Crohn Disease, Inflammatory Bowel Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡